KCNB1 Down (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with KCNB1 Down.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with KCNB1 Down.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with KCNB1 Down.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with KCNB1 Down.

Results found

Linked to

 

Label

Description

 

Gene

ENSG00000177383 - MAGE family member F1

Gene

ENSG00000076984 - mitogen-activated protein kinase kinase 7

Gene

ENSG00000109738 - glycine receptor beta

Gene

ENSG00000006740 - Rho GTPase activating protein 44

Gene

ENSG00000122012 - synaptic vesicle glycoprotein 2C

Gene

ENSG00000163635 - ataxin 7

Gene

ENSG00000158258 - calsyntenin 2

Gene

ENSG00000149435 - gamma-glutamyltransferase light chain 1

Gene

ENSG00000087076 - hydroxysteroid 17-beta dehydrogenase 14

  • Gene

    ENSG00000177383 - MAGE family member F1


  • Gene

    ENSG00000076984 - mitogen-activated protein kinase kinase 7


  • Gene

    ENSG00000109738 - glycine receptor beta


  • Gene

    ENSG00000006740 - Rho GTPase activating protein 44


  • Gene

    ENSG00000122012 - synaptic vesicle glycoprotein 2C


  • Gene

    ENSG00000163635 - ataxin 7


  • Gene

    ENSG00000158258 - calsyntenin 2


  • Gene

    ENSG00000149435 - gamma-glutamyltransferase light chain 1


  • Gene

    ENSG00000087076 - hydroxysteroid 17-beta dehydrogenase 14

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.